Canadian Urological Association Annual Meeting Coverage

Morbid Obesity Worsens PCNL Outcomes

Complication and retreatment rates are higher than in normal-weight patients, Canadian study finds.

Ultra-Low CT Dose Accurately Detects Renal Stones

Ultra-Low CT Dose Accurately Detects Renal Stones

It has a sensitivity of 92% and a specificity of 100%.

Ureteroscopy Overtakes SWL for Ureteral Stone Treatment

Technological advancements in ureteroscopes are among the reasons.

Aspirin Use May Increase Prostate Cancer Risk

Aspirin use was associated with a twofold higher odds having prostate cancer detected.

Study Shows Benefits of Active Surveillance for Low-Risk PCa

Active surveillance for low-risk prostate cancer is associated with a low risk for progression and very good 10-year cancer-specific survival.

HoLEP for Large Prostates Offers Good Outcomes

Findings emerged from a study of BPH patients with prostates weighing 200 grams or more.

Bladder Cancer Survival Linked to COX-2

TORONTO—Patients with muscle-invasive bladder cancer whose tumors express cyclooxygenase-2 (COX-2) appear to have improved disease-specific survival.

Laser Lithotripsy Safe for Obese Patients

Stone-free rates and the incidence of post-op complications are similar to those of the nonobese

SWL Not As Effective for Stones in Horseshoe Kidneys

TORONTO—Patients with horseshoe kidneys appear to have lower single-treatment success and stone-free rates after shock-wave lithotripsy (SWL) than patients with normal kidneys, data suggest.

Statins May Prevent PSA Relapse

Prostate cancer patients who use statins may be at lower risk of PSA recurrence after radical prostatectomy (RP) compared with those who do not use the medications, according to investigators.

Sign Up for Free e-newsletters